A threshold value for the time delay to TB diagnosis.
BACKGROUND
In many communities where TB occurs at high incidence, the major force driving the epidemic is transmission. It is plausible that the typical long delay from the onset of infectious disease to diagnosis and commencement of treatment is almost certainly the major factor contributing to the high rate of transmission.


RESULTS
This study is confined to communities which are epidemiologically relatively isolated and which have low HIV incidence. The consequences of delays to diagnosis are analyzed and the existence of a threshold delay value is demonstrated. It is shown that unless a sufficient number of cases are detected before this threshold, the epidemic will escalate. The method used for the analysis avoids the standard computer integration of systems of differential equations since the intention is to present a line of reasoning that reveals the essential dynamics of an epidemic in an intuitively clear way that is nevertheless quantitatively realistic.


CONCLUSIONS
The analysis presented here shows that typical delays to diagnosis present a major obstacle to the control of a TB epidemic. Control can be achieved by optimizing the rapid identification of TB cases together with measures to increase the threshold value. A calculated and aggressive program is therefore necessary in order to bring about a reduction in the prevalence of TB in a community by decreasing the time to diagnosis in all its ramifications. Intervention strategies to increase the threshold value relative to the time to diagnosis and which thereby decrease disease incidence are discussed.
Uys
Pieter W
PW
Division of Molecular Biology and Human Genetics, MRC Center for Molecular and Cellular Biology, Faculty of Health Sciences, Stellenbosch University, Cape Town, Western Cape, Republic of South Africa.
Warren
Robin M
RM
van Helden
Paul D
PD
D004198:Disease Susceptibility; D015658:HIV Infections / Q000453:epidemiology; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000472:pathogenicity; D013019:South Africa / Q000453:epidemiology; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis* / Q000453:epidemiology* / Q000635:transmission
J Microbiol Methods. 2001 May;45(1):41-52
11295196
Int J Tuberc Lung Dis. 2006 Jan;10(1):24-30
16466033
J Clin Microbiol. 1986 May;23(5):822-5
3086369
Lancet. 1983 Sep 17;2(8351):651-2
6136798
Am J Respir Crit Care Med. 2000 Dec;162(6):2033-8
11112109
J Clin Microbiol. 1992 Sep;30(9):2415-8
1401008
J Theor Biol. 2000 Oct 7;206(3):327-41
10988019
JAMA. 2002 Feb 27;287(8):996-1002
11866647
Pediatrics. 2004 Jun;113(6):e514-9
15173530
Scand J Infect Dis. 2001;33(4):279-84
11345220
Trans R Soc Trop Med Hyg. 2005 Dec;99(12):893-900
16139316
Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1244-8
9563746
JAMA. 2002 Feb 27;287(8):991-5
11866646
Kekkaku. 1994 May;69(5):375-7
8007524
Annu Rev Public Health. 2004;25:303-26
15015922
Int J Epidemiol. 2004 Apr;33(2):351-7
15082639
Int J Tuberc Lung Dis. 1999 Dec;3(12):1088-95
10599012
Int J Tuberc Lung Dis. 2000 Feb;4(2):133-8
10694091
J Clin Microbiol. 2000 Jun;38(6):2278-83
10834989
J Infect Dis. 2007 Aug 15;196 Suppl 1:S15-27
17624822